THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Health Beliefs, Glycemic Control, and Preventing Cognitive Decline in African Americans with Diabetes and Mild Cognitive Impairment: a Randomized Clinical Trial

Phase 2

Completed

Conditions: Mild Cognitive Impairment
Diabetes

Interventions: Behavioral: Diabetes Regulation for Eyesight and Memory
Behavioral: Enhanced Usual Care

First Posted Date: 2020-02-06

Last Posted Date: 2024-11-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 145

Registration Number: NCT04259047

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

IV Iron vs Oral Iron for Treatment of Anemia in Women With Abnormal Uterine Bleeding

Phase 4

Recruiting

Conditions: Anemia, Iron Deficiency
Heavy Menstrual Bleeding

Interventions: Drug: Ferrous Sulfate
Drug: Ferumoxytol

First Posted Date: 2019-12-19

Last Posted Date: 2023-11-21

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 76

Registration Number: NCT04205266

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy

Phase 1

Completed

Conditions: Pancreas Cancer
DVT
Pulmonary Embolism

Interventions: Drug: Apixaban

First Posted Date: 2019-12-10

Last Posted Date: 2021-12-23

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 4

Registration Number: NCT04191928

Locations: 🇺🇸
Thomas Jefferson University Clinical Research Unit, Philadelphia, Pennsylvania, United States

Head to Head Comparison of Upper Airway Stimulation and Continuous Positive Airway Pressure; a Pilot Study.

Recruiting

Conditions: Obstructive Sleep Apnea

First Posted Date: 2019-12-09

Last Posted Date: 2024-04-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 50

Registration Number: NCT04191512

Locations: 🇺🇸
Thomas Jefferson University Department of Otolaryngology, Philadelphia, Pennsylvania, United States

Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCC

Early Phase 1

Recruiting

Conditions: Recessive Dystrophic Epidermolysis Bullosa

Interventions: Drug: Rigosertib Sodium
Other: Quality-of-Life Assessment

First Posted Date: 2019-11-26

Last Posted Date: 2024-10-23

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 6

Registration Number: NCT04177498

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

POCUS Analysis of the Gastric Emptying Time of Orange Juice With and Without Pulp

Not Applicable

Completed

Conditions: Preoperative Period
Anesthesia

Interventions: Other: Point of care gastric ultrasound

First Posted Date: 2019-10-31

Last Posted Date: 2020-03-18

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 14

Registration Number: NCT04146233

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Patients With Heart Failure With Preserved Ejection Fraction Adherence to ASV Therapy (PEP ASV)

Not Applicable

Terminated

Conditions: Heart Failure
Sleep Disorder; Breathing-Related

Interventions: Behavioral: Active Patient Engagement

First Posted Date: 2019-10-21

Last Posted Date: 2021-05-27

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 2

Registration Number: NCT04133350

Locations: 🇩🇪
Herz- und Diabeteszentrum, Nordrhein-Westfalen, Bad Oeynhausen, Ruhr-Universität Bochum, Germany
🇩🇪
Ludgerus Clinic, Department of Cardiology, Clemens Hospital, Münster, Germany
🇺🇸
INOVA (Inova Heart and Vascular Institute, Inova Fairfax Hospital), Falls Church, Virginia, United States

and more 1 locations

Pharmacist-led Transitions of Care in the Outpatient Oncology Infusion Center for Patients With Solid Tumor

Not Applicable

Completed

Conditions: Malignant Solid Neoplasm

Interventions: Other: Medical Chart Review
Other: Educational Intervention
Other: Survey Administration

First Posted Date: 2019-10-10

Last Posted Date: 2022-08-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 26

Registration Number: NCT04122118

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Acceptance and Commitment Therapy vs. Supportive Psychotherapy With Cystic Fibrosis Patients

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Behavioral: Acceptance and Commitment Therapy adapted for Cystic Fibrosis (ACT with CF)
Behavioral: Supportive Psychotherapy (Treatment as Usual Control)

First Posted Date: 2019-10-03

Last Posted Date: 2024-04-15

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 146

Registration Number: NCT04114227

Locations: 🇺🇸
Jefferson Center City Clinic for Behavioral Medicine, Philadelphia, Pennsylvania, United States

A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma

Phase 2

Suspended

Conditions: Pancreatic Ductal Adenocarcinoma
Clinical Stage IIA Gastric Cancer AJCC v8
Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage IIB Gastric Cancer AJCC v8
Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8
Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8
Pathologic Stage III Gastric Cancer AJCC v8
Pathologic Stage IIIA Gastric Cancer AJCC v8
Pathologic Stage IIIC Gastric Cancer AJCC v8
Stage I Pancreatic Cancer AJCC v8

Interventions: Biological: Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE

First Posted Date: 2019-10-01

Last Posted Date: 2024-05-13

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 81

Registration Number: NCT04111172

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy